Acrospire Investment Management’s Adaptimmune Therapeutics ADAP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q1
Sell
-400
Closed -$2K 2181
2016
Q4
$2K Buy
+400
New +$2K ﹤0.01% 2119